Michael Eisenhut

13.7k total citations · 5 hit papers
214 papers, 10.1k citations indexed

About

Michael Eisenhut is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Eisenhut has authored 214 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Radiology, Nuclear Medicine and Imaging, 55 papers in Molecular Biology and 45 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Eisenhut's work include Radiopharmaceutical Chemistry and Applications (55 papers), Medical Imaging Techniques and Applications (18 papers) and Tuberculosis Research and Epidemiology (16 papers). Michael Eisenhut is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (55 papers), Medical Imaging Techniques and Applications (18 papers) and Tuberculosis Research and Epidemiology (16 papers). Michael Eisenhut collaborates with scholars based in Germany, United Kingdom and United States. Michael Eisenhut's co-authors include Uwe Haberkorn, Walter Mier, Matthias Eder, Martin Schäfer, Ali Afshar‐Oromieh, Jae Il Shin, Klaus Kopka, Ulrike Bauder‐Wüst, Carmen Wängler and Eugenio Ragazzi and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Michael Eisenhut

207 papers receiving 9.9k citations

Hit Papers

Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patie... 2012 2026 2016 2021 2015 2012 2017 2015 2014 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
    2015 813 citations Michael Eisenhut et al. Journal of Nuclear Medicine profile →
  2. 68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
    2012 688 citations Martin Schäfer, Ulrike Bauder‐Wüst et al. profile →
  3. Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
    2017 400 citations Ali Afshar‐Oromieh, Frederik L. Giesel et al. European Journal of Nuclear Medicine and Molecular Imaging profile →
  4. The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions
    2015 332 citations Ali Afshar‐Oromieh, Clemens Kratochwil et al. Journal of Nuclear Medicine profile →
  5. Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer
    2014 317 citations Ulrike Bauder‐Wüst, Martin Schäfer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Eisenhut Germany 48 4.2k 3.6k 2.1k 1.9k 1.3k 214 10.1k
Daniel E. Fürst United States 64 1.4k 0.3× 1.8k 0.5× 2.1k 1.0× 1.4k 0.7× 2.2k 1.7× 258 22.1k
L. Maximilian Buja United States 71 3.7k 0.9× 2.2k 0.6× 4.5k 2.1× 865 0.5× 1.4k 1.0× 515 18.5k
Alwin D. R. Huitema Netherlands 56 793 0.2× 2.0k 0.6× 2.9k 1.4× 4.3k 2.3× 1.2k 0.9× 552 12.9k
Daniel E. Furst United States 73 927 0.2× 3.8k 1.0× 2.0k 1.0× 1.2k 0.7× 2.2k 1.7× 382 17.5k
Hui Gan Australia 46 1.2k 0.3× 1.2k 0.3× 1.9k 0.9× 2.4k 1.3× 433 0.3× 326 7.5k
Sang‐Cheol Bae South Korea 59 1.8k 0.4× 703 0.2× 2.1k 1.0× 1.6k 0.8× 1.6k 1.2× 501 16.5k
Bruce Furie United States 72 1.3k 0.3× 1.9k 0.5× 5.6k 2.6× 1.3k 0.7× 1.0k 0.8× 238 19.1k
Pierce K. H. Chow Singapore 65 1.3k 0.3× 2.7k 0.8× 3.3k 1.5× 3.9k 2.1× 2.6k 2.0× 384 14.4k
Romano Danesi Italy 61 753 0.2× 3.4k 0.9× 5.7k 2.7× 6.0k 3.2× 905 0.7× 441 13.6k
David Murray United States 48 2.3k 0.6× 834 0.2× 4.0k 1.9× 1.5k 0.8× 1.1k 0.8× 286 9.7k

Countries citing papers authored by Michael Eisenhut

Since Specialization
Citations

This map shows the geographic impact of Michael Eisenhut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Eisenhut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Eisenhut more than expected).

Fields of papers citing papers by Michael Eisenhut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Eisenhut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Eisenhut. The network helps show where Michael Eisenhut may publish in the future.

Co-authorship network of co-authors of Michael Eisenhut

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Eisenhut. A scholar is included among the top collaborators of Michael Eisenhut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Eisenhut. Michael Eisenhut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kay, Alexander, Tara Ness, Pauline Amuge, et al.. (2025). Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children. Cochrane Database of Systematic Reviews. 2026(1). CD013359–CD013359.
2.
Eisenhut, Michael, et al.. (2024). Uncovering Diaphragm Cramp in SIDS and Other Sudden Unexpected Deaths. Diagnostics. 14(20). 2324–2324. 1 indexed citations
3.
Jeong, Gwang Hun, Keum Hwa Lee, Ji Hyun Oh, et al.. (2019). Incidence of Capillary Leak Syndrome as an Adverse Effect of Drugs in Cancer Patients: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 8(2). 143–143. 42 indexed citations
4.
Kronbichler, Andreas, Daniel Fernando Pereira Vasconcelos, Felipe Rodolfo Pereira da Silva, et al.. (2019). Genetic Variants in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Bayesian Approach and Systematic Review. Journal of Clinical Medicine. 8(2). 266–266. 18 indexed citations
5.
Shin, Jae Il, Keum Hwa Lee, Ji Hyun Oh, et al.. (2018). Systemic Capillary Leak Syndrome (Clarkson Syndrome) in Cancer Patients: A Systematic Review. Journal of Clinical Medicine. 7(11). 418–418. 21 indexed citations
6.
Vijendren, Ananth, Matthew M Coates, Matthew E. Smith, et al.. (2017). Management of pinna haematoma study (MaPHaeS): A multicentre retrospective observational study. Clinical Otolaryngology. 42(6). 1252–1258. 5 indexed citations
7.
Kim, Ji Young, et al.. (2017). Clinical Presentation, Management, and Prognostic Factors of Idiopathic Systemic Capillary Leak Syndrome: A Systematic Review. The Journal of Allergy and Clinical Immunology In Practice. 6(2). 609–618. 58 indexed citations
8.
Afshar‐Oromieh, Ali, John W. Babich, Clemens Kratochwil, et al.. (2016). The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer. Journal of Nuclear Medicine. 57(Supplement 3). 79S–89S. 208 indexed citations
9.
Hennrich, Ute, Lisa Seyler, Martin Schäfer, et al.. (2012). Synthesis and in vitro evaluation of 68Ga-DOTA-4-FBn-TN14003, a novel tracer for the imaging of CXCR4 expression. Bioorganic & Medicinal Chemistry. 20(4). 1502–1510. 24 indexed citations
10.
Eisenhut, Michael, et al.. (2011). Hair-analysis for acetyl-isoniazid/isoniazid ratio and N-acetyl-transferase-2-genotype in patients on treatment for mycobacterium tuberculosis infection. European Respiratory Journal. 38(Suppl 55). p1825–p1825. 1 indexed citations
11.
Haberkorn, Uwe, Michael Eisenhut, Annette Altmann, & Walter Mier. (2009). Molecular endoradiotherapy of cancer. 21(1). 5–19. 1 indexed citations
12.
Zitzmann-Kolbe, Sabine, Susanne Krämer, Christel Herold‐Mende, et al.. (2009). Identification and Characterization of a Peptide with Affinity to Head and Neck Cancer. Journal of Nuclear Medicine. 50(3). 426–434. 37 indexed citations
13.
Haberkorn, Uwe, W Kübler, Michael Eisenhut, et al.. (2004). Iodide kinetics and dosimetry in vivo after transfer of the human sodium iodide symporter gene in rat thyroid carcinoma cells.. PubMed. 45(5). 827–33. 16 indexed citations
14.
Henze, Marcus, Jochen Schuhmacher, Antonia Dimitrakopoulou‐Strauss, et al.. (2004). Exceptional increase in somatostatin receptor expression in pancreatic neuroendocrine tumour, visualised with 68 Ga-DOTATOC PET. European Journal of Nuclear Medicine and Molecular Imaging. 31(3). 466–466. 23 indexed citations
15.
Hoffend, Johannes, et al.. (2003). 99mTcO(BAT-NI), a novel nitroimidazole tracer: in vivo uptake studies in ischaemic myocardium. European Journal of Nuclear Medicine and Molecular Imaging. 30(4). 494–501. 6 indexed citations
16.
Haberkorn, Uwe, Marcus Henze, Annette Altmann, et al.. (2001). Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells.. PubMed. 42(2). 317–25. 90 indexed citations
17.
Eisenhut, Michael, Wolf D. Lehmann, William E. Hull, et al.. (1997). Trapping and metabolism of radioiodinated PHIPA 3-10 in the rat myocardium.. PubMed. 38(12). 1864–9. 4 indexed citations
18.
Eisenhut, Michael, et al.. (1995). Dialkylaminoalkyl-4-Iodobenzamides: Influence of Specific Activity and Substituents on Melanoma Uptake and Biodistribution.. Journal of Labelled Compounds and Radiopharmaceuticals. 37. 277–279. 3 indexed citations
19.
Eisenhut, Michael, et al.. (1994). Simple kit formulated conjugation of NHS-BAT ester to monoclonal antibodies. Journal of Labelled Compounds and Radiopharmaceuticals. 35. 395–397. 1 indexed citations
20.
Liefhold, J. & Michael Eisenhut. (1986). Synthesis, labeling, and pharmacokinetics of 131I labeled phenylene-iodophenyl-fatty acids (PHIPA). Journal of Labelled Compounds and Radiopharmaceuticals. 23. 1239–1241. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel E. Fürst Breakdown of academic impact, for papers by L. Maximilian Buja Breakdown of academic impact, for papers by Alwin D. R. Huitema Breakdown of academic impact, for papers by Daniel E. Furst Breakdown of academic impact, for papers by Hui Gan Breakdown of academic impact, for papers by Sang‐Cheol Bae Breakdown of academic impact, for papers by Bruce Furie Breakdown of academic impact, for papers by Pierce K. H. Chow Breakdown of academic impact, for papers by Romano Danesi Breakdown of academic impact, for papers by David Murray
Rankless by CCL
2026